NA Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030

NA Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030
North America Digital Polymerase Chain Reaction (PCR) market is expected to reach USD 5,937.67 million by 2030 from USD 2,626.89 million in 2022, growing at a CAGR of 11.4% during the forecast period of 2023 to 2033.
Market Segmentation
North America Digital Polymerase Chain Reaction (PCR) Market, By Product type (Digital PCR Instruments, Consumables and Reagents, Software and Services), Technology (Droplet Digital PCR, Beaming Digital PCR), Application (Clinical, Life Science & Research and Others), End Users (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories and Others), Distribution Channel (Direct Tenders, Retail Sales, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2030

Overview of North America Digital Polymerase Chain Reaction (PCR) Market Dynamics

Drivers

• Rise in Availability of Digital PCR Diagnostics
• Increasing Application of Digital PCR

Restraints

• Limitations in Analyzing Novel Complex Devices
• High Cost of Digital PCR Devices

Opportunity

• Rising Product Innovations through Research and Development Activities

Market Players

Some of the major market players operating in the North America digital polymerase chain reaction (PCR) market are:

• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• QIAGEN
• Eppendorf SE
• Sysmex Corporation
• Stilla
• RainSure Scientific
• Accumax
• Standard BioTools Inc
• JN Medsys
• VSI Electronics Pvt. Ltd
• Precigenome LLC